InvestorsHub Logo
Followers 35
Posts 1771
Boards Moderated 0
Alias Born 09/25/2012

Re: PNW_Ironman post# 32310

Sunday, 12/23/2018 10:29:04 PM

Sunday, December 23, 2018 10:29:04 PM

Post# of 232920
LJPC La Jolla Pharmaceuticals did a reverse stock split and uplist. Ran to $45 per share and is now back down to $12 per share but the drop has to do with market prospects, and bad market selling.

ADXS did a large stock split from .04 cents per share to $4 or $5 per share I think it was a 1 for 200 r/s or something like that. Anyways on good news it ran to $30 per share now down to .20 cents per share.

The point is those companies ran higher after doing a reverse stock split and uplisting to NASDAQ. You can check the history at those times when they did the uplist and r/s they did so when there was no phase 3 done and no FDA approval yet.

Cytoydn has already completed a combination phase 3, and ready to file a BLA. Plus it is near on possibly finishing up the monotherapy as well with a label expansion.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent CYDY News